Use (or planned use during the study period) of any investigational or non-registered product or off-label use of licensed product (drug or vaccine).

Chronic administration of immunosuppressants or other immune-modifying drugs occurring less than three months prior to blood sampling.

Administration of immunoglobulins and/or any blood products within the three months preceding blood sampling.

Planned administration of any HPV vaccine, other than that foreseen by the study protocol, during the study period.

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine